Paul Conyngham is a tech entrepreneur from Sydney, an electrical engineer by training, with no medical degree, no lab, and no pharmaceutical backing.
In 2024, his dog Rosie was diagnosed with cancer. They tried chemotherapy and surgery, but the tumours kept growing. Rosie kept getting weaker. Every vet said there's nothing more they can do.
Conyngham didn't accept it.
He opened ChatGPT and used it the way a researcher would. He asked it to map every possible treatment direction, every specialist worth contacting, every piece of relevant science published in the last decade. ChatGPT pointed him to the University of New South Wales Ramaciotti Centre for Genomics.
He called them, convinced their scientists to take his case seriously, and paid for Rosie's full genomic sequencing out of his own pocket.
Then he used AlphaFold, Google DeepMind's AI protein-mapping tool, to scan Rosie's DNA and find the exact mutations driving her cancer. Mutations that could be targeted.
Now, he needed someone to build this weapon.
A nanomedicine scientist named Pall Thordarson said yes. Using the same mRNA technology behind COVID vaccines, he built a cancer vaccine designed specifically for Rosie's tumours, and only Rosie's tumours.
It took less than two months. Rosie got her first injection in December and a booster in February. Now, six months later, most of her tumours have shrunk. She's not cured, but she's running again.
Now think about it.
This entire thing, from diagnosis to custom vaccine, costs a fraction of what pharmaceutical trials cost. It happened outside a drug company, outside a hospital system, and outside the traditional gatekeepers of medicine.
Why did this happen now and not 10 years ago?
Because ten years ago, you needed a PhD to even know what questions to ask. You needed a research institution's budget to sequence a genome and years to map proteins.
Today, ChatGPT asks the right questions for you. AlphaFold maps proteins in hours, and Genomic sequencing costs a few thousand dollars. A determined person with no medical background just designed a cancer vaccine using tools that are free or nearly free and available to anyone on the internet.
Thordarson said it best:
"Personalized medicine can be done in a time-sensitive manner. What Rosie is teaching us, we're going to use this for humans."
This is what happened when AI met a parent who refuses to give up.
Imagine what happens when it meets a doctor!!
Musk just announced the world's biggest chip factory. It launches this Saturday.
Every major AI company buys chips from TSMC in Taiwan. One geopolitical crisis and the entire AI industry stalls. Musk's fix is Tesla's "Terafab Project," a chip fab described as "like a Gigafactory but way, way bigger," that launches March 21.
This targets 100–200 billion chips per year on American soil. The global AI supply chain just got a challenger.
A lawyer who handles AI death cases just said the worst is still coming.
Last month's Canada school shooting. A man who showed up armed to an airport because his chatbot said it was being held captive there. A study tested 10 major AI chatbots asking them to help plan attacks. Well, 8 out of 10 helped.
Only Claude refused. The lawyer leading multiple AI-linked death cases now gets one serious inquiry every single day. His words are: "First suicides. Then murders. Now mass casualty events."
NVIDIA just declared the next era of AI. It doesn't live on your screen.
Jensen Huang at GTC 2026 made one thing clear: the next wave of AI isn't a chatbot but a robot on a factory floor, a machine in a warehouse, a system in a hospital.
NVIDIA announced a full platform for AI that operates in the physical world. Every major automaker and robotics company was in the room. The age of AI you can touch just officially began.
FAST BREAK
Elon Musk's own AI company wasn't built right. So he's rebuilding it from scratch.
xAI, the company behind Grok, the AI Musk built to beat OpenAI, is doing a full architectural restart. This is not an update but a ground-up rebuild.
The man who is racing everyone to AGI just hit Ctrl+Z on his own AI company.
The funniest part? This is apparently not the first time.